Back
Fate Therapeutics Vs. ADMA Biologics Industry Stock Comparison
Sell
27
FATE
Fate Therapeutics
Last Price:
4.08
Seasonality Move:
-2.97%
Buy
93
ADMA
ADMA Biologics
Last Price:
6.65
Seasonality Move:
3.59%
Sell
27
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $4.09. The Score for FATE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
93
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $6.67. The Score for ADMA is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $4.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight selling pressure.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $6.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADMA is experiencing slight buying pressure.
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 27.41 | Sell |
| Chaikin Money Flow: | -288156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.41 - 6.83) | Sell |
| Bollinger Bands (100): | (3.9 - 7.16) | Sell |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 62.39 | Buy |
| Chaikin Money Flow: | 678604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.12 - 6.56) | Buy |
| Bollinger Bands (100): | (4.63 - 6.27) | Buy |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.17 | Sell |
| 20-day SMA: | 5.24 | Sell |
| 50-day SMA: | 6.46 | Sell |
| 200-day SMA: | 4.06 | Buy |
| 8-day EMA: | 4.26 | Sell |
| 20-day EMA: | 5.03 | Sell |
| 50-day EMA: | 5.7 | Sell |
| 200-day EMA: | 5.72 | Sell |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.5 | Buy |
| 20-day SMA: | 6.29 | Buy |
| 50-day SMA: | 6.12 | Buy |
| 200-day SMA: | 4.59 | Buy |
| 8-day EMA: | 6.5 | Buy |
| 20-day EMA: | 6.36 | Buy |
| 50-day EMA: | 6.07 | Buy |
| 200-day EMA: | 4.89 | Buy |
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.22 per share.
Fate Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||